Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound oral liquid for treating poultry colibacillosis mixed infection

A technology for poultry colibacillosis and mixed infection, which is applied in the direction of antibacterial drugs, pharmaceutical formulas, and medical preparations containing active ingredients, which can solve the problems of slow onset of effect, high price, and poor treatment effect, and achieve rapid onset of effect , significant curative effect, and the effect of solving the symptoms of persistent fever in poultry

Active Publication Date: 2012-05-02
ZHENGZHOU BARY ANIMAL PHARMA
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the mixed infection of avian colibacillosis has seriously affected the healthy development of poultry production, so there are many drugs used to treat the mixed infection of avian colibacillosis on the market, but there are still some problems as follows, such as slow onset , poor treatment effect, expensive, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0013] The compound oral liquid for the treatment of colibacillosis mixed infection in poultry provided by the present embodiment, every 100L oral liquid is made up of following components: Houttuynia cordata distillate 15L, amikacin sulfate 1kg, gentamicin sulfate 0.5kg, lactic acid Trimethoprim 0.2kg, nicotinamide 3kg, dexamethasone sodium phosphate 0.01kg, sodium bisulfite 0.1kg, lactic acid 0.1L, and the balance is purified water.

[0014] The preparation method of the compound oral liquid for the treatment of avian colibacillosis mixed infection provided by the present embodiment is as follows:

[0015] (1) Accurately measure 15L of Houttuynia cordata distillate, 0.1L of lactic acid, weigh 1kg of amikacin sulfate, 0.5kg of gentamicin sulfate, 0.2kg of trimethoprim lactate, 3kg of nicotinamide, and dexamethasone phosphate Sodium 0.01kg, sodium bisulfite 0.1kg;

[0016] (2) Measure 50L of purified water, and weigh amikacin sulfate, gentamicin sulfate, trimethoprim lactate,...

Embodiment 2

[0020] The compound oral liquid for the treatment of colibacillosis mixed infection in poultry provided by the present embodiment, every 100L oral liquid is made up of following components: Houttuynia cordata distillate 25L, amikacin sulfate 0.5kg, gentamycin sulfate 1kg, lactic acid Trimethoprim 0.05kg, nicotinamide 8kg, dexamethasone sodium phosphate 0.05kg, sodium bisulfite 0.3kg, lactic acid 0.5L, and the balance is purified water.

[0021] The preparation method of the compound oral liquid for the treatment of avian colibacillosis mixed infection provided by the present embodiment is as follows:

[0022] (1) Accurately measure 25L of Houttuynia cordata distillate, 0.5L of lactic acid, weigh 0.5kg of amikacin sulfate, 1kg of gentamicin sulfate, 0.05kg of trimethoprim lactate, 8kg of nicotinamide, and dexamethasone phosphate Sodium 0.05kg, sodium bisulfite 0.3kg;

[0023] (2) Measure 50L of purified water, and weigh amikacin sulfate, gentamicin sulfate, trimethoprim lactat...

Embodiment 3

[0027] The compound oral liquid for the treatment of colibacillosis mixed infection in poultry provided by the present embodiment, every 100L oral liquid is made up of following components: Houttuynia cordata distillate 20L, amikacin sulfate 1kg, gentamicin sulfate 0.5kg, lactic acid Trimethoprim 0.1kg, nicotinamide 5kg, dexamethasone sodium phosphate 0.02kg, sodium bisulfite 0.2kg, lactic acid 0.3L, and the balance is purified water.

[0028] The preparation method of the compound oral liquid for the treatment of avian colibacillosis mixed infection provided by the present embodiment is as follows:

[0029] (1) Accurately measure 20L of Houttuynia cordata distillate, 0.3L of lactic acid, weigh 1kg of amikacin sulfate, 0.5kg of gentamicin sulfate, 0.1kg of trimethoprim lactate, 5kg of nicotinamide, and dexamethasone phosphate Sodium 0.02kg, sodium bisulfite 0.2kg;

[0030] (2) Measure 50L of purified water, and weigh amikacin sulfate, gentamicin sulfate, trimethoprim lactate,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of animal medicines, and in particular discloses compound oral liquid for treating poultry colibacillosis mixed infection. Each 100L of compound oral liquid for treating poultry colibacillosis mixed infection consists of the following components: 15 to 25L of heartleaf houttuynia herb distillate, 0.5 to 1kg of amikacin sulfate, 0.5 to 1kg of gentamicinsulfate, 0.05 to 0.2kg of trimethoprim lactate, 3 to 8kg of nicotinamide, 0.01 to 0.05kg of dexamethasone sodium phosphate, 0.1 to 0.3kg of sodium hydrogensulfite, 0.1 to 0.5L of lactic acid and the balance of purified water. The compound oral liquid for treating poultry colibacillosis mixed infection has the advantages that: antibacterial and antiviral effects are obvious, and poultry persistentfever symptoms caused by poultry colibacillosis mixed infection can be relieved, so that the organism function of poultry is quickly recovered; and the oral liquid has quick response and an obvious curative effect and is conveniently and safely used.

Description

technical field [0001] The invention relates to the technical field of animal medicines, in particular to a compound oral liquid for treating colibacillosis mixed infection in poultry. Background technique [0002] In recent years, the incidence of poultry diseases has shown a mixed infection trend, such as avian E. The complexity of the disease has brought great difficulties to diagnosis and treatment, and also caused great economic losses to farmers. According to the survey, the mixed infection of avian colibacillosis is the most common among the mixed infection diseases of poultry. At present, the mixed infection of avian colibacillosis is widely prevalent in most farms, the morbidity and mortality remain high, and outbreaks have occurred in many places. The main clinical manifestations are listlessness, decreased feed intake, snoring, mouth breathing, loose yellow-white-green stools, decreased egg production rate of laying hens, and a large number of deaths. According ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/78A61P31/04A61K31/19A61K31/455A61K31/505A61K31/573A61K31/7036A61K33/04
Inventor 郭玉凡王佳伟杨晶张宁张峰军
Owner ZHENGZHOU BARY ANIMAL PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com